Tobacco Control Press Releases
Today, September 9, is the court-ordered deadline for manufacturers of e-cigarettes and certain other tobacco products to apply to the U.S. Food and Drug Administration to keep their products on the market.
As manufacturers of e-cigarettes and certain other tobacco products face a September 9, 2020, deadline to apply to the U.S. Food and Drug Administration to keep their products on the market, six leading public health and medical organizations today urged the FDA not to authorize the sale of any flavored product
SACRAMENTO, CA - With the Assembly Health Committee set to take a historic vote on Senate Bill (SB) 793 (Hill D-San Mateo) to finally end the sale of all -flavored tobacco products this Tuesday, public health advocates believe the tobacco industry’s all-out lobbying and advertisi
Today the U.S. House of Representatives voted on an FY 2021 spending bill that includes a $5.5 billion funding increase for the National Institutes of Health (NIH). Half of the increase would be considered emergency funding and the other half would be divided among the various institutes, including a nearly $470 million funding boost for the National Cancer Institute (NCI).
ST. PAUL, Minn. – Three pieces of legislation that reduce Minnesota’s cancer burden go into effect August 1st.
Setting a dangerous precedent that puts kids and public health at risk, today the U.S. Food and Drug Administration authorized the marketing of Philip Morris’ IQOS heated cigarette as a “modified risk tobacco product” despite the FDA’s acknowledgement that Philip Morris failed to show that IQOS presents a reduced risk of tobacco-related disease...
JACKSON, MS – June 29, 2020 – Senate Bill 2596 has moved quickly through the Legislature in an effort to regulate e-cigarettes.
CHICAGO, Ill. – Public health advocates applaud efforts by Ald. Matt O’Shea and Ald. Roderick Sawyer to protect Chicago kids from flavored tobacco and a lifetime of addiction. Ald. O’Shea, Ald.
LANSING, MI – The unpredictable and dynamic nature of COVID-19 is no match for the steadfast commitment of the American Cancer Society Cancer Action Network (ACS CAN) volunteers.